Exosomes boost CBD's cancer-fighting power through targeted delivery

Researchers have developed an innovative delivery system for cannabidiol (CBD) using exosomes—tiny natural carriers derived from cells—to overcome a major challenge in cannabis medicine: poor oral absorption. In this study, CBD was loaded onto exosomes, with some enhanced using folic acid targeting to seek out cancer cells. The folic acid-functionalized exosomes (FA-ExoCBD) were only about 136 nanometers in size, small enough to be absorbed through the digestive tract while remaining stable in acidic stomach conditions. When tested against different breast cancer cell types, CBD proved particularly effective against triple-negative breast cancer (TNBC), a highly aggressive form with limited treatment options, showing significantly better results than against hormone-positive breast cancers.

In laboratory and animal studies, the exosomal CBD formulations demonstrated enhanced tumor targeting and growth inhibition compared to free CBD, with the folic acid-enhanced version performing best. Critically, oral administration of FA-ExoCBD in mice reduced tumor growth more effectively than either standard exosomal CBD or unformulated CBD. The research revealed that CBD modulated over 1,000 genes in tumor tissues, particularly downregulating genes associated with metastasis and tumor growth while activating natural tumor-suppressing genes. These genetic changes suggest CBD works through multiple biological pathways to fight cancer, not just a single mechanism.

This breakthrough addresses a fundamental problem in cannabis medicine: most oral CBD has poor bioavailability, meaning the body doesn't absorb or utilize much of what's taken. By packaging CBD in exosomes and using folic acid as a targeting mechanism, scientists achieved improved efficacy, better tumor selectivity, and superior oral absorption. While these results are from laboratory and animal studies, they suggest that next-generation CBD formulations could offer cancer patients a more effective, naturally-derived therapeutic option with potentially fewer side effects than conventional chemotherapy.